NDC 59630-266

Fetroja

Cefiderocol Sulfate Tosylate

Fetroja is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Shionogi Inc.. The primary component is Cefiderocol Sulfate Tosylate.

Product ID59630-266_4aba0315-09ac-4d81-be81-a98f688a5adf
NDC59630-266
Product TypeHuman Prescription Drug
Proprietary NameFetroja
Generic NameCefiderocol Sulfate Tosylate
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-01-31
Marketing CategoryNDA / NDA
Application NumberNDA209445
Labeler NameShionogi Inc.
Substance NameCEFIDEROCOL SULFATE TOSYLATE
Active Ingredient Strength1 g/10mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 59630-266-10

10 VIAL, SINGLE-USE in 1 CARTON (59630-266-10) > 10 mL in 1 VIAL, SINGLE-USE (59630-266-01)
Marketing Start Date2020-01-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59630-266-01 [59630026601]

Fetroja INJECTION, POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA209445
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-01-31

NDC 59630-266-10 [59630026610]

Fetroja INJECTION, POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA209445
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CEFIDEROCOL SULFATE TOSYLATE1 g/10mL

Trademark Results [Fetroja]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FETROJA
FETROJA
86890071 5288628 Live/Registered
Shionogi & Co., Ltd.
2016-01-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.